Skip to content

Clinical trials

Prostatic Hyperplasia trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Prostatic Hyperplasia Country / region: France Clear all

59 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20051
20062
20072
20081
20094
20106
20112
20123
20132
20144
20151
20165
20173
20181
20202
20215
20224
20232
20243
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed40
Terminated5
Recruiting4
Active, not recruiting3
Not yet recruiting3
Unknown status3
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Assistance Publique - Hôpitaux de Paris7
GlaxoSmithKline5
University Hospital, Bordeaux5
Eli Lilly and Company4
Pierre Fabre Medicament3
Allergan2
Assistance Publique Hopitaux De Marseille2
Astellas Pharma Europe B.V.2
Boston Scientific Corporation2
Centre Hospitalier Universitaire de Nice2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Prostatic Hyperplasia59
Lower Urinary Tract Symptoms10
Prostatic Neoplasms3
Adenoma1
Erectile Dysfunction1
Hypothermia1
Inflammation1
Multiple Endocrine Neoplasia Type 11
Urinary Bladder Neoplasms1
Urinary Bladder, Overactive1

Trials

Showing 51 to 59 of 59. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.